Johns Hopkins University will begin two clinical trials of convalescent blood plasma to treat COVID-19 next week.<br />Convalescent blood plasma is plasma derived from the blood of COVID-19 survivors.<br />According to UPI, researchers said the trials will focus on healthcare workers and nursing home residents.<br />Researchers theorize that the blood from recovered patients contains antibodies that may fight the virus.<br />Doctors hope that treatment will cut down on the need to hospitalize patients.<br />The goal is to give the plasma to patients while they are at home, before respiratory distress sets in.
